About
About WINMEDIC
Built on more than 25 years of deep-rooted industry expertise, WINMEDIC is dedicated to advancing digital pathology and unlocking diagnostic value through intelligent pathology solutions.
As a National High-Tech Enterprise and a Provincial Specialized-and-Sophisticated Enterprise, WINMEDIC holds ISO 9001 and ISO 13485 certifications alongside more than 90 intellectual property assets. We deliver a full-stack portfolio spanning brightfield and fluorescence imaging, AI-driven analysis and tele-pathology — a platform that has scanned over 10 million slides and serves more than 2,800 healthcare institutions worldwide. Rooted in China and serving partners across the globe, we continue to drive precise, intelligent pathology diagnosis for the future.
Our Purpose
Mission
Advance digital diagnostics and empower user-centric value creation.
Vision
To become a global leader in the digital pathology industry.
Philosophy
Make pathological medical diagnosis more accurate through digital intelligence.
Values
Joint development for customers, employees and the enterprise.
Our Journey
- WINMEDIC was formally established, bringing together a talent team with 20 years of experience across pathology, life sciences, mechanical design and artificial intelligence.
- Launched the 1-slide digital slide scanner Science, gaining rapid traction with domestic customers.
- Obtained the NMPA registration certificate for the medical image transmission & consultation system.
- Launched the Win-series digital slide scanning system.
- Awarded National High-Tech Enterprise certification.
- Passed ISO 9001 and ISO 13485 certification.
- Hosted the first Partner Summit for ecosystem building.
- Awarded Innovative SME and Shandong Specialized-and-Sophisticated SME titles.
- Established the Overseas Department and acquired our first international customer, marking the start of a global strategy.
- Launched the high-throughput scanner HS480; the fluorescence scanner SMART obtained NMPA certification.
- Made our global academic debut at the IAP Thailand conference.
- Developed and launched the Win-Pro series, integrating brightfield and fluorescence imaging.
- Awarded Gazelle Enterprise qualification; products obtained CE certification.
- Released the DP450 automatic tissue processor and DP-MASTER AI analysis software, completing our full-stack digital pathology layout.
- Recognized as a Shandong-Made brand enterprise and a Shandong First-set Technical Equipment manufacturer.
- The Win-Pro series was officially granted the NMPA registration certificate.
- Overseas channels now cover more than 50 countries across Europe, the Americas, Central Asia, Southeast Asia and Africa.
- Formed a dual-product-line strategy: medical-oriented and research-oriented portfolios for focused market execution.
Talent-Driven Innovation
WINMEDIC builds a lean, high-performance team spanning R&D, global marketing and operational support. Our R&D and technical teams account for over 40% of total headcount — our largest functional group — continuously iterating on products and core technologies. Sales and marketing represent approximately 20%, connecting us with customers worldwide, while production, quality and administration keep the organization running efficiently.
Within the next two years, we aim to triple our high-end R&D talent and expand our global clinical support and international sales teams. Long-term commitment from management ensures sustainable innovation and global market expansion.
Customer Success & Support
WINMEDIC operates a four-level after-sales support framework covering on-site installation training, remote diagnostics, periodic maintenance and rapid response services. We maintain equipment uptime above 99% and customer satisfaction at or above 95%, with critical issues responded to within 24 hours.
We take part in top-tier global pathology academic conferences to lead industry insight, while our Partner Summits deliver technical training, strategy alignment and case sharing that foster a mutually beneficial global channel ecosystem.
Our Global Vision for the Next Five Years
Market Globalization
Achieve a cumulative global installed base of over 5,000 units and expand our footprint across 70+ countries and regions, with local operation and technical service hubs in key markets across Europe, the Americas and Southeast Asia.
Professional Brand Position
Rank among the top five global end-to-end digital pathology solution providers and become the preferred vendor in selected vertical segments.
Ecosystem Collaboration
Grow to 80+ contracted global partners for a mature channel and service network, launching multiple standardized digital pathology solutions for diverse clinical and research scenarios based on our dual “Medical + Research” product lines.
Technology Roadmap
Realize multi-modal data fusion — evolving from single-image analysis to interconnected data networks for data-driven intelligent diagnosis. Participate in domestic and international standard-setting projects for digital pathology and AI pathology.
